Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris
JAAD Case Reports（2023）
摘要
Pemphigus Vulgaris (PV) is a subgroup of IgG-mediated autoimmune blistering diseases targeting desmosomal adhesion proteins, desmoglein (Dsg) 1 and Dsg 3.1 Systemic corticosteroids are the current first-line treatment. Other treatments aimed at disease control include immunosuppressive and immunomodulatory agents, such as azathioprine, mycophenolate mofetil, cyclosporine, intravenous immunoglobulin, dapsone, and rituximab.
更多查看译文
关键词
case report,drug response,dupilumab,general dermatology,medical dermatology,oncology,pemphigus,vesiculobullous
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要